Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
September 8, 2021
Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data
James L Weaver, Wendy Wu, Paula L Hyland, et al.
Current Drug Discovery Technologies
|
February 14, 2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling
Edwin J Matthews, Naomi L Kruhlak, James L Weaver, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 3, 2014
Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release
Krishna C Chimalakonda, Eric Pang, James L Weaver, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Evaluation of a Sequential Antibiotic Treatment Regimen of Ampicillin, Ciprofloxacin and Fosfomycin against <i>Escherichia coli</i> CFT073 in the Hollow Fiber Infection Model Compared with Simultaneous Combination Treatment
Ashok Krishna, Tesfalem Zere, Sabyasachy Mistry, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 30, 2003
Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components
Karol L Thompson, Barry A Rosenzweig, James L Weaver, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 10, 2019
BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains
James L Weaver, Leah M Zadrozny, Kathleen Gabrielson, et al.
Physical Review Letters
|
March 21, 2008
Enhanced direct-drive implosions with thin high-Z ablation layers
Andrew N Mostovych, Denis G Colombant, Max Karasik, et al.
Toxicologic Pathology
|
June 30, 2010
Early events in vascular injury in the rat induced by the phosphodiesterase IV inhibitor SCH 351591
James L Weaver, Jun Zhang, Alan Knapton, et al.
International Journal of Antimicrobial Agents
|
December 16, 2019
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model
Narayana Garimella, Tesfalem Zere, Neil Hartman, et al.
Toxicology and Applied Pharmacology
|
March 28, 2019
Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models
Hangyi Yan, Bhagyashree Bhagwat, David Sanden, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
September 8, 2021
Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data
James L Weaver, Wendy Wu, Paula L Hyland, et al.
Current Drug Discovery Technologies
|
February 14, 2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling
Edwin J Matthews, Naomi L Kruhlak, James L Weaver, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 3, 2014
Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release
Krishna C Chimalakonda, Eric Pang, James L Weaver, et al.
Antibiotics (Basel, Switzerland)
|
December 23, 2022
Evaluation of a Sequential Antibiotic Treatment Regimen of Ampicillin, Ciprofloxacin and Fosfomycin against <i>Escherichia coli</i> CFT073 in the Hollow Fiber Infection Model Compared with Simultaneous Combination Treatment
Ashok Krishna, Tesfalem Zere, Sabyasachy Mistry, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 30, 2003
Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components
Karol L Thompson, Barry A Rosenzweig, James L Weaver, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 10, 2019
BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains
James L Weaver, Leah M Zadrozny, Kathleen Gabrielson, et al.
Physical Review Letters
|
March 21, 2008
Enhanced direct-drive implosions with thin high-Z ablation layers
Andrew N Mostovych, Denis G Colombant, Max Karasik, et al.
Toxicologic Pathology
|
June 30, 2010
Early events in vascular injury in the rat induced by the phosphodiesterase IV inhibitor SCH 351591
James L Weaver, Jun Zhang, Alan Knapton, et al.
International Journal of Antimicrobial Agents
|
December 16, 2019
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model
Narayana Garimella, Tesfalem Zere, Neil Hartman, et al.
Toxicology and Applied Pharmacology
|
March 28, 2019
Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models
Hangyi Yan, Bhagyashree Bhagwat, David Sanden, et al.
Page
of 5